ALI,ZAHID Z,BUTCHER,KENNETH JOHN KJ,BUTT,RICHARD PHILIP RP,FELSTEAD,STEPHER JOHN SJ,GLATT,SOPHIE S,MCKERNAN,RUTH MITCHELL RM,PANESAR,MANINDER M,.阿裡,.布徹,.巴特,.費爾斯特德,.格拉特,.麥克南,.帕內薩
申请号：
HK16108332.2
公开号：
HK1220198A
申请日:
2014.10.07
申请国别(地区):
HK
年份:
2017
代理人:
摘要：
The present invention is directed to 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide or a pharmaceutically acceptable salt thereof for the treatment of a disease associated with elevated blood uric acid levels, such as hyperuricemia or gout. The invention is also directed to the tosylate salt of 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide.
